1. Home
  2. ARWR vs TIGO Comparison

ARWR vs TIGO Comparison

Compare ARWR & TIGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$63.20

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Logo Millicom International Cellular S.A.

TIGO

Millicom International Cellular S.A.

HOLD

Current Price

$68.39

Market Cap

10.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARWR
TIGO
Founded
2003
1990
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
10.4B
IPO Year
1993
1994

Fundamental Metrics

Financial Performance
Metric
ARWR
TIGO
Price
$63.20
$68.39
Analyst Decision
Strong Buy
Buy
Analyst Count
11
4
Target Price
$77.55
$53.95
AVG Volume (30 Days)
3.1M
1.1M
Earning Date
02-05-2026
02-26-2026
Dividend Yield
N/A
4.48%
EPS Growth
N/A
601.37
EPS
1.48
6.46
Revenue
$1,090,981,000.00
$5,594,000,000.00
Revenue This Year
N/A
$0.14
Revenue Next Year
N/A
$17.84
P/E Ratio
$43.74
$10.33
Revenue Growth
43539.24
N/A
52 Week Low
$9.57
$25.50
52 Week High
$76.76
$67.26

Technical Indicators

Market Signals
Indicator
ARWR
TIGO
Relative Strength Index (RSI) 43.36 77.73
Support Level $66.91 $59.37
Resistance Level $76.11 $62.74
Average True Range (ATR) 4.11 1.95
MACD -0.77 0.67
Stochastic Oscillator 12.48 95.79

Price Performance

Historical Comparison
ARWR
TIGO

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About TIGO Millicom International Cellular S.A.

Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to acquire Telefonica's operations in Ecuador and Uruguay.

Share on Social Networks: